Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Champion

Showing results (51-60 of 149) with videos related to

Pageof 15
Sort By:
Agents and Actions. Supplements|January 1, 1988
Aspects of the clinical trials of slow-acting anti-rheumatic drugsR O Day, S N Breit, D Cairns, et al.
British Journal of Clinical Pharmacology|May 1, 1985
Stereoselective disposition of ibuprofen enantiomers in manE J Lee, K Williams, R Day, et al.
International Nursing Review|April 22, 2005
Risk and protective behaviours of bisexual minority women: a qualitative analysisJ D Champion, K Wilford, R N Shain, et al.
Australian and New Zealand Journal of Medicine|December 1, 1982
Antimalarials in rheumatic diseasesR O Day, P Sambrook, G D Champion, et al.
Biochemical Pharmacology|June 1, 1990
The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytesR Rudkowski, G G Graham, G D Champion, et al.
Biochemical Pharmacology|June 15, 1991
Auranofin inhibits the activation pathways of polymorphonuclear leukocytes at multiple sitesR Rudkowski, J B Ziegler, G G Graham, et al.
Clinics in Rheumatic Diseases|August 1, 1984
Anti-rheumatic drug interactionsR O Day, G G Graham, G D Champion, et al.
The Journal of Rheumatology|May 1, 1991
The effect of aurothiomalate on the oxidative burst of polymorphonuclear leukocytes varies with the quantity of drug in myocrisin ampoulesR Rudkowski, G G Graham, J B Ziegler, et al.
Arthritis and Rheumatism|November 1, 1974
Letter: Serum uric acid determinationH W Emori, G D Champion, R Bluestone, et al.
Annals of the Rheumatic Diseases|September 1, 1973
Simultaneous pharmacokinetics of indomethacin in serum and synovial fluidH W Emori, G D Champion, R Bluestone, et al.
Pageof 15

Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Agents and Actions. Supplements|January 1, 1988
Aspects of the clinical trials of slow-acting anti-rheumatic drugsR O Day, S N Breit, D Cairns, et al.
British Journal of Clinical Pharmacology|May 1, 1985
Stereoselective disposition of ibuprofen enantiomers in manE J Lee, K Williams, R Day, et al.
International Nursing Review|April 22, 2005
Risk and protective behaviours of bisexual minority women: a qualitative analysisJ D Champion, K Wilford, R N Shain, et al.
Australian and New Zealand Journal of Medicine|December 1, 1982
Antimalarials in rheumatic diseasesR O Day, P Sambrook, G D Champion, et al.
Biochemical Pharmacology|June 1, 1990
The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytesR Rudkowski, G G Graham, G D Champion, et al.
Biochemical Pharmacology|June 15, 1991
Auranofin inhibits the activation pathways of polymorphonuclear leukocytes at multiple sitesR Rudkowski, J B Ziegler, G G Graham, et al.
Clinics in Rheumatic Diseases|August 1, 1984
Anti-rheumatic drug interactionsR O Day, G G Graham, G D Champion, et al.
The Journal of Rheumatology|May 1, 1991
The effect of aurothiomalate on the oxidative burst of polymorphonuclear leukocytes varies with the quantity of drug in myocrisin ampoulesR Rudkowski, G G Graham, J B Ziegler, et al.
Arthritis and Rheumatism|November 1, 1974
Letter: Serum uric acid determinationH W Emori, G D Champion, R Bluestone, et al.
Annals of the Rheumatic Diseases|September 1, 1973
Simultaneous pharmacokinetics of indomethacin in serum and synovial fluidH W Emori, G D Champion, R Bluestone, et al.
Pageof 15